Central nervous system activities of hypericum origanifolium extract via GABAergic and opioidergic mechanisms

Phytotherapy Research

Volumn 27, Issue 6, 2013, Pages 877-884

  Yaşar, Şahin Nuri ^a   Can, Özgür Devrim ^a   Öztürk, Nilgün ^a   Sagratini, Gianni ^b   Ricciutelli, Massimo ^b   Vittori, Sauro ^b   Maggi, Filippo ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

antidepressant; antinociceptive; anxiolytic; chlorogenic acid; Hypericum origanifolium; rutin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; CHLOROGENIC ACID; DIAZEPAM; HYPERFORIN; HYPERICIN; HYPERICUM ORIGANIFOLIUM EXTRACT; HYPERIN; ISOQUERCITRIN; MORPHINE SULFATE; PLANT EXTRACT; QUERCETIN; QUERCITRIN; REBOXETINE; RUTOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTINOCICEPTION; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; EMOTION; GABAERGIC SYSTEM; HYPERICUM; HYPERICUM ORIGANIFOLIUM; LOCOMOTION; MALE; MOTOR COORDINATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PHYTOCHEMISTRY; TRANQUILIZING ACTIVITY;

ANALGESICS; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; CHLOROGENIC ACID; HYPERICUM; MALE; MICE; PAIN PERCEPTION; PLANT EXTRACTS; RUTIN;

CLUSIACEAE; HYPERICUM; MUS;

EID: 84878849280     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4801     Document Type: Article

References (45)

1. Beerhues L,. 2006. Hyperforin. Phytochemistry 67: 2201-2207.
2. Bonkanka CX, Sánchez-Mateo CD, Rabanal RM,. 2011. Antinociceptive activity of Hypericum grandifolium Choisy in mice. J Nat Med 65: 122-128.
3. Bouayed J, Rammal H, Dicko A, Younos C, Soulimani R,. 2007. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J Neurol Sci 262: 77-84.
4. Butterweck V, Jurgenliemk G, Nahrstedt A, Winterhoff H,. 2000. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med 66: 3-6.
5. Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H,. 2003. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Life Sci 73: 627-639.
6. Can OD, Ozkay UD,. 2012. Effects of Hypericum montbretti extract on the central nervous system and involvement of GABA (A)/benzodiazepine receptors in its pharmacological activity. Phytother Res in press. DOI: 10.1002/ptr.4629.
7. Can OD, Ozkay UD, Kaplancikli ZA, Oztürk Y,. 2009. Effects of some 1,3,5-trisubstitued-2-pyrazoline derivatives on depression and anxiety parameters of mice. Arch Pharm Res 32: 1293-1299.
8. Can OD, Ozkay UD, Oztürk N, Oztürk Y,. 2010. Effects of Hawthorn seed and pulp extracts on the central nervous system. Pharm Biol 48: 924-931.
9. Can OD, Ismail IB, Oztürk Y, et al,. 2011. New antidepressant drug candidate: Hypericum montbretti extract. Nat Prod Res 25: 1469-1472.
10. Cervo L, Rozio M, Ekalle-Soppo CB, Guiso G, Morazzoni P, Caccia S,. 2002. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology 164: 423-428.
11. Chavez ML, Chavez PI,. 1997. Monographs on alternative therapies: Saint John's Wort. Hosp Pharm 32: 1621-1632.
12. Cryan JF, Markou A, Lucki I,. 2002. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238-245.
13. Demir Ozkay U, Can OD, Kaplancikli ZA,. 2012. Antinociceptive activities of some triazole and pyrazoline moieties-bearing compounds. Med Chem Res 21: 1056-1061.
14. Diana G, Capasso A, Quaranta E, De Feo V,. 2007. Differential effects of three species of Hypericum in an open field test. Phytother Res 21: 15-19.
15. Dimpfel W,. 2009. Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. Phytomedicine 16: 287-294.
16. Dos Santos MD, Almeida MC, Lopes NP, De Souza GE,. 2006. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29: 2236-2240.
17. Fernández SP, Wasowski C, Loscalzo LM, et al,. 2006. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539: 168-176.
18. Gabra BH, Sirois P,. 2003. Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides 24: 1131-1139.
19. Haas JS, Stolz ED, Betti AH, et al,. 2010. The anti-immobility effect of hyperoside on the forced swimming test in rats is mediated by the D2-like receptors activation. Planta Med 77: 334-339.
20. Holzl J, Demisch L, Gollnik B,. 1989. Investigations about antidepressive and mood changing effects of Hypericum perforatum. Planta Med 55: 643.
21. Kaplancikli ZA, Altintop MD, Turan-Zitouni G, Ozdemir A, Can OD,. 2012. Synthesis and analgesic activity of some acetamide derivatives. J Enzyme Inhib Med Chem 27: 275-280.
22. Lapa Fda R, Gadotti VM, Missau FC, et al,. 2009. Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata L. in mice. Basic Clin Pharmacol Toxicol 104: 306-315.
23. Le Bars D, Gozariu M, Cadden SW,. 2001. Animal models of nociception. Pharmacol Rev 53: 597-652.
24. Machado DG, Bettio LE, Cunha MP, et al,. 2008. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 587: 163-168.
25. Marder M, Paladini AC,. 2002. GABAA-receptor ligands of flavonoid structure. Curr Top Med Chem 2: 853-867.
26. Nassiri-Asl M, Shariati-Rad S, Zamansoltani F,. 2008. Anticonvulsive effects of intracerebroventricular administration of rutin in rats. Prog Neuropsychopharmacol Biol Psychiatry 32: 989-993.
27. Noldner M, Schotz K,. 2002. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 68: 577-580.
28. Öztürk N, Tunçel M, Potoǧlu-Erkara İ,. 2009. Phenolic compounds and antioxidant activities of some Hypericum species: a comparative study with H. perforatum. Pharm Biol 47: 120-127.
29. Paulke A, Nöldner M, Schubert-Zsilavecz M, Wurglics M,. 2008. St. John's Wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie 63: 296-302.
30. Rabanal RM, Bonkanka CX, Hernández-Pérez M, Sánchez-Mateo CC,. 2005. Analgesic and topical anti-inflammatory activity of Hypericum canariense L. and Hypericum glandulosum Ait. J Ethnopharmacol 96: 591-596.
31. Rad SS, Asl MN, Zamansoltani F,. 2008. Anticonvulsive effects of rutin in a rat model of absence seizure: a novel compound to treat seizure. Ann Gen Psychiatr 7: 219.
32. Rylski M, Duriasz-Rowińska H, Rewerski W,. 1979. The analgesic action of some flavonoids in the hot-plate test. Acta Physiol Pol 30: 385-388.
33. Sánchez-Mateo CC, Bonkanka CX, Prado B, Rabanal RM,. 2005. Antidepressant properties of some Hypericum canariense L. and Hypericum glandulosum Ait. extracts in the forced swimming test in mice. J Ethnopharmacol 97: 541-547.
34. Sánchez-Mateo CC, Bonkanka CX, Hernández-Pérez M, Rabanal RM,. 2006. Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. Fil. J Ethnopharmacol 107: 1-6.
35. Seo JJ, Lee SH, Lee YS, et al,. 2007. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog Neuropsychopharmacol Biol Psychiatry 31: 1363-1369.
36. Suzuki O, Katsumata Y, Oya M, Bladt S, Wagner H,. 1984. Inhibition of monoamine oxidase by hypericin. Planta Med 50: 272-274.
37. Takeda H, Tsuji M, Miyamoto J, Masuya J, Iimori M, Matsumiya T,. 2003. Caffeic acid produces antidepressive- and/or anxiolytic-like effects through indirect modulation of the alpha 1A-adrenoceptor system in mice. Neuroreport 14: 1067-1070.
38. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K,. 1992. The formalin test: an evaluation of the method. Pain 51: 5-17.
39. Venâncio ET, Rocha NF, Rios ER, et al,. 2011. Anxiolytic-like effects of standardized extract of Justicia pectoralis (SEJP) in mice: involvement of GABA/Benzodiazepine in receptor. Phytother Res 25: 444-450.
40. Viana AF, Heckler AP, Fenner R, Rates SM,. 2003. Antinociceptive activity of Hypericum caprifoliatum and Hypericum polyanthemum (Guttiferae). Braz J Med Biol Res 36: 631-634.
41. Viana A, Rates S, Naudin B, Janin F, Costentin J, Do Rego JC,. 2008. Effects of acute or 3-day treatments of Hypericum caprifoliatum cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels. J Psychopharmacol 22: 681-690.
42. Wang D, Bai J, Sun F, Yang D,. 2010. Chemical constituents and antidepressant activity of the new species Hypericum enshiense occurring in China. Phytomedicine 17: 410-413.
43. Yonathan M, Asres K, Assefa A, Bucar F,. 2006. In vivo anti-inflammatory and anti-nociceptive activities of Cheilanthes farinosa. J Ethnopharmacol 108: 462-470.
44. Zanoli P,. 2004. Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev 10: 203-218.
45. Zapata-Sudo G, Mendes TC, Kartnaller MA, et al,. 2010. Sedative and anticonvulsant activities of methanol extract of Dorstenia arifolia in mice. J Ethnopharmacol 130: 9-12.